Q-linea AB (publ) (QLINEA.ST)
SEK 0.04
(-1.92%)
SEK 0.04
(-1.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -210.98 Million SEK | 13.0% |
| 2022 | -252.68 Million SEK | -10.64% |
| 2021 | -218.47 Million SEK | -5.2% |
| 2020 | -211.01 Million SEK | -22.31% |
| 2019 | -172.52 Million SEK | -38.78% |
| 2018 | -124.31 Million SEK | -87.97% |
| 2017 | -66.15 Million SEK | -13.16% |
| 2016 | -58.44 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -52.36 Million SEK | -2.96% |
| 2024 Q2 | -60.89 Million SEK | -19.22% |
| 2023 Q2 | -60.1 Million SEK | -5.55% |
| 2023 FY | - SEK | 13.0% |
| 2023 Q1 | -56.94 Million SEK | 1.47% |
| 2023 Q4 | -50.9 Million SEK | -16.84% |
| 2023 Q3 | -43.56 Million SEK | 27.51% |
| 2022 FY | - SEK | -10.64% |
| 2022 Q4 | -57.79 Million SEK | -3.5% |
| 2022 Q3 | -55.84 Million SEK | 20.41% |
| 2022 Q2 | -70.16 Million SEK | -1.86% |
| 2022 Q1 | -68.88 Million SEK | -41.85% |
| 2021 Q2 | -65.26 Million SEK | -7.1% |
| 2021 FY | - SEK | -5.2% |
| 2021 Q3 | -47.23 Million SEK | 27.62% |
| 2021 Q4 | -48.56 Million SEK | -2.81% |
| 2021 Q1 | -60.93 Million SEK | -12.04% |
| 2020 FY | - SEK | -22.31% |
| 2020 Q4 | -54.38 Million SEK | -12.53% |
| 2020 Q2 | -55.43 Million SEK | -2.49% |
| 2020 Q3 | -48.33 Million SEK | 12.82% |
| 2020 Q1 | -54.08 Million SEK | 10.19% |
| 2019 Q2 | -43.02 Million SEK | -22.2% |
| 2019 FY | - SEK | -38.78% |
| 2019 Q4 | -60.22 Million SEK | -76.81% |
| 2019 Q3 | -34.06 Million SEK | 20.83% |
| 2019 Q1 | -35.2 Million SEK | 7.15% |
| 2018 Q2 | -35.16 Million SEK | -49.84% |
| 2018 Q3 | -27.76 Million SEK | 21.04% |
| 2018 Q1 | -23.46 Million SEK | -9.76% |
| 2018 Q4 | -37.92 Million SEK | -36.57% |
| 2018 FY | - SEK | -87.97% |
| 2017 FY | - SEK | -13.16% |
| 2017 Q2 | -15.87 Million SEK | -8.8% |
| 2017 Q3 | -15.58 Million SEK | 1.84% |
| 2017 Q4 | -21.38 Million SEK | -37.22% |
| 2017 Q1 | -14.58 Million SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AddLife AB (publ) | 1.54 Billion SEK | 113.647% |
| Biotage AB (publ) | 432 Million SEK | 148.839% |
| Bonesupport Holding AB (publ) | 28.93 Million SEK | 829.122% |
| Doxa AB (publ) | 296 Million SEK | 171.279% |
| Elekta AB (publ) | 3.29 Billion SEK | 106.411% |
| iZafe Group AB (publ) | -15.61 Million SEK | -1251.002% |
| Ortivus AB (publ) | -14.92 Million SEK | -1313.547% |
| Ortivus AB (publ) | -14.92 Million SEK | -1313.547% |
| S2Medical AB (publ) | -13.52 Million SEK | -1459.495% |
| Synsam AB (publ) | 1.71 Billion SEK | 112.331% |